Hisamitsu Drug Patent Portfolio
Hisamitsu owns 1 orange book drug protected by 6 US patents Given below is the list of Hisamitsu's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11813364 | Patch | 22 Sep, 2033 | Active |
| US10022445 | Patch | 25 Jul, 2033 | Active |
| US10583121 | Patch | 25 Jul, 2033 | Active |
| US10814002 | Patch and method for producing the same | 25 Jul, 2033 | Active |
| US11123305 | Patch | 25 Jul, 2033 | Active |
| US9687474 | Patch | 25 Jul, 2033 | Active |
Latest Legal Activities on Hisamitsu's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Hisamitsu.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Apr, 2024 | US10814002 |
| Mail Patent eGrant Notification | 14 Nov, 2023 | US11813364 |
| Recordation of Patent eGrant | 14 Nov, 2023 | US11813364 |
|
Recordation of Patent Grant Mailed
Critical
| 14 Nov, 2023 | US11813364 |
|
Email Notification
Critical
| 14 Nov, 2023 | US11813364 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 14 Nov, 2023 | US11813364 |
| Patent eGrant Notification | 14 Nov, 2023 | US11813364 |
|
Email Notification
Critical
| 27 Oct, 2023 | US11813364 |
|
Issue Notification Mailed
Critical
| 25 Oct, 2023 | US11813364 |
| Dispatch to FDC | 11 Oct, 2023 | US11813364 |
|
Application Is Considered Ready for Issue
Critical
| 11 Oct, 2023 | US11813364 |
|
Issue Fee Payment Verified
Critical
| 09 Oct, 2023 | US11813364 |
|
Issue Fee Payment Received
Critical
| 09 Oct, 2023 | US11813364 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 23 Aug, 2023 | US10583121 |
|
Electronic Review
Critical
| 27 Jul, 2023 | US11813364 |
Hisamitsu's Family Patents
Hisamitsu drugs have patent protection in a total of 9 countries. It's US patent count contributes only to 34.1% of its total global patent coverage. Click
below to unlock the full patent family tree.
Hisamitsu Drug List
Given below is the complete list of Hisamitsu's drugs and the patents protecting them.
1. Secuado
Secuado is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11813364 | Patch |
22 Sep, 2033
(8 years from now)
| Active |
| US10022445 | Patch |
25 Jul, 2033
(8 years from now)
| Active |
| US10583121 | Patch |
25 Jul, 2033
(8 years from now)
| Active |
| US10814002 | Patch and method for producing the same |
25 Jul, 2033
(8 years from now)
| Active |
| US11123305 | Patch |
25 Jul, 2033
(8 years from now)
| Active |
| US9687474 | Patch |
25 Jul, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Secuado's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List